Skip to main content

Pancreatic adenocarcinoma, version 2.2014: featured updates to the NCCN guidelines.

Publication ,  Journal Article
Tempero, MA; Malafa, MP; Behrman, SW; Benson, AB; Casper, ES; Chiorean, EG; Chung, V; Cohen, SJ; Czito, B; Engebretson, A; Feng, M; Herman, J ...
Published in: J Natl Compr Canc Netw
August 2014

The NCCN Guidelines for Pancreatic Adenocarcinoma discuss the diagnosis and management of adenocarcinomas of the exocrine pancreas and are intended to assist with clinical decision-making. These NCCN Guidelines Insights summarize major discussion points from the 2014 NCCN Pancreatic Adenocarcinoma Panel meeting. The panel discussion focused mainly on the management of borderline resectable and locally advanced disease. In particular, the panel discussed the definition of borderline resectable disease, role of neoadjuvant therapy in borderline disease, role of chemoradiation in locally advanced disease, and potential role of newer, more active chemotherapy regimens in both settings.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

J Natl Compr Canc Netw

DOI

EISSN

1540-1413

Publication Date

August 2014

Volume

12

Issue

8

Start / End Page

1083 / 1093

Location

United States

Related Subject Headings

  • Pancreatic Neoplasms
  • Oncology & Carcinogenesis
  • Neoadjuvant Therapy
  • Humans
  • Guidelines as Topic
  • Antineoplastic Combined Chemotherapy Protocols
  • Adenocarcinoma
  • 4203 Health services and systems
  • 3211 Oncology and carcinogenesis
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Tempero, M. A., Malafa, M. P., Behrman, S. W., Benson, A. B., Casper, E. S., Chiorean, E. G., … Freedman-Cass, D. A. (2014). Pancreatic adenocarcinoma, version 2.2014: featured updates to the NCCN guidelines. J Natl Compr Canc Netw, 12(8), 1083–1093. https://doi.org/10.6004/jnccn.2014.0106
Tempero, Margaret A., Mokenge P. Malafa, Stephen W. Behrman, Al B. Benson, Ephraim S. Casper, E Gabriela Chiorean, Vincent Chung, et al. “Pancreatic adenocarcinoma, version 2.2014: featured updates to the NCCN guidelines.J Natl Compr Canc Netw 12, no. 8 (August 2014): 1083–93. https://doi.org/10.6004/jnccn.2014.0106.
Tempero MA, Malafa MP, Behrman SW, Benson AB, Casper ES, Chiorean EG, et al. Pancreatic adenocarcinoma, version 2.2014: featured updates to the NCCN guidelines. J Natl Compr Canc Netw. 2014 Aug;12(8):1083–93.
Tempero, Margaret A., et al. “Pancreatic adenocarcinoma, version 2.2014: featured updates to the NCCN guidelines.J Natl Compr Canc Netw, vol. 12, no. 8, Aug. 2014, pp. 1083–93. Pubmed, doi:10.6004/jnccn.2014.0106.
Tempero MA, Malafa MP, Behrman SW, Benson AB, Casper ES, Chiorean EG, Chung V, Cohen SJ, Czito B, Engebretson A, Feng M, Hawkins WG, Herman J, Hoffman JP, Ko A, Komanduri S, Koong A, Lowy AM, Ma WW, Merchant NB, Mulvihill SJ, Muscarella P, Nakakura EK, Obando J, Pitman MB, Reddy S, Sasson AR, Thayer SP, Weekes CD, Wolff RA, Wolpin BM, Burns JL, Freedman-Cass DA. Pancreatic adenocarcinoma, version 2.2014: featured updates to the NCCN guidelines. J Natl Compr Canc Netw. 2014 Aug;12(8):1083–1093.

Published In

J Natl Compr Canc Netw

DOI

EISSN

1540-1413

Publication Date

August 2014

Volume

12

Issue

8

Start / End Page

1083 / 1093

Location

United States

Related Subject Headings

  • Pancreatic Neoplasms
  • Oncology & Carcinogenesis
  • Neoadjuvant Therapy
  • Humans
  • Guidelines as Topic
  • Antineoplastic Combined Chemotherapy Protocols
  • Adenocarcinoma
  • 4203 Health services and systems
  • 3211 Oncology and carcinogenesis